Inventor · disambiguated record

Stephen Mccolgan, Md

Also filed as: MCCOLGAN MD STEPHEN · MCCOLGAN MD STEPHEN J · MCCOLGAN STEPHEN · MCCOLGAN STEPHEN J

0 granted patents·9 pending applications·0 citations·filing 2021–2022

Technology areasA61K

Files withVIVERA PHARMACEUTICALS INC9

Top patents by PatentIndex Score

9 records

0172US2022062189A1Sublingual Delivery for Mitigation of Side Effects Associated with Sildenafil CitrateVIVERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
0271US2021401757A1Sublingual delivery for mitigation of side effects associated with olanzapine and metforminVIVERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
0371US2021401758A1Sublingual delivery for mitigation of side effects associated with trazodoneVIVERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
0454US2023114360A1Sublingual Delivery for Mitigation of Side Effects Associated with ZicronapineVIVERA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
0552US2022023223A1Sublingual delivery for mitigation of side effects associated with blonanserinVIVERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
0650US2022168226A1Sublingual delivery for mitigation of side effects associated with metforminVIVERA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
0750US2022117900A1Sublingual delivery for mitigation of side effects associated with vortioxetineVIVERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
0850US2022096387A1Sublingual delivery for mitigation of side effects associated with lurasidoneVIVERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
0950US2022117901A1Sublingual delivery for mitigation of side effects associated with brexpiprazoleVIVERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites

Join the waitlist — get patent alerts

Get an alert when Stephen Mccolgan, Md files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →